NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM280555 Query DataSets for GSM280555
Status Public on Apr 10, 2008
Title L_258
Sample type RNA
 
Source name Lung Biopsy
Organism Homo sapiens
Characteristics Phenotype: NSCLC-NOS
gender: 0
age: 66
status: 0
Surv: 1001
stage: IIIb
T: 4
N: 2
M: 0
mat: bx
Tumor Prop: 2
Extracted molecule total RNA
Extraction protocol Lysis and homogeneization is performed with 1 mL pre-warmed (60°C) TRIzol Reagent (Invitrogen Cat. No. 15596-026) and 5 mm stainless steel beads (Qiagen Cat. No. 69989, 2 times 2 min at 25 Hz in tissue lyser Mixer Mill 300 for 2-3 mm Ø biopsies). The extraction is completed by adding Phase Lock Gel (Eppendorf Cat. No. 0032007.970) during the phase extraction. Molecular biology grade glycogen (Roche Diagnostics GmbH, Cat. N. 901393) is added to the aqueous phase during the precipitation step. After purification step on RNeasy Microkit columns (Qiagen, Cat. No. 74004), the final cleaned total RNA is eluted in 14 µL of RNase free water and stored at -80°C. RNA levels, quality and purity are assessed with the use of RNA 6000 Nano and Pico assay on the Agilent 2100 Bioanalyzer.
Label Cy5
Label protocol Commercial human reference RNA (Stratagene) was labeled per protocol and materials of the Ambion labelling kit (#1753). Labeling of RNA samples will be based on Ambion Amino Allyl MessageAmp II aRNA Amplification Kit (#q1753). 50 ng of total RNA was used for each labeling. The first step is a reverse transcription to synthesize first-strand cDNA with an oligo(dT) primer with a T7 promoter. Subsequently, the second-strand cDNA is synthesized. The cDNA was used for processing with the Ambion kit according to the protocol as template for in vitro transcription (IVT) with T7 RNA polymerase. During this amplification step, 5-(3- aminoallyl)-UTP (aaUTP) is incorporated into the cRNA. The resulting amplified RNA (aRNA) is then chemically coupled to N-hydroxysuccinimidyl ester-derivatized Cy5-dyes (NHS ester Cy5-dyes). Once purified, concentration and yield/dye incorporation are determined. The labeled products are aliquoted and stored at -80°C for further use
 
Hybridization protocol A Tecan HS 4800 Hybridization station from Tecan, Inc. is used for prewash/hybridization/postwash of the microarrays. Prewash consists of 3 cycles with wash buffer at RT/75°C/50°C (each 20 s) followed by an additional 10 s wash with hybridization buffer at 50°C. One hundred L sample (100 ng labeled RNA) in hybridization buffer is then injected into the flow chambers at 50°C and agitated for 1 min. Subsequently, after 10 min at 75°C, the temperature is adjusted to 42°C for 16 h (agitation). The postwash consists in 4 cycles wash buffer at 42°C followed by an additional wash at 23°C (each 20 s). Finally, the slides are washed 3 times with diluted wash buffer at RT, dried in N2 stream, and scanned immediately with an Agilent LS fluorescence scanner (gain 80%).
Scan protocol Agilent laser scanner at 100% gain, 10micron resolution, Cy5 channel. Files stored as 16bit TIF.
Description Tissue samples from a series of 41 chemotherapy-naïve non-small cell lung cancer patients and 15 control patients with inflammatory lung diseases.
Data processing The fluorescence images is analyzed by means of Array Pro (Mediacybernetics, Inc. US). Net signals is calculated by subtracting the 75 percentile of local corner background from trimmed mean of each spot (20% trimming on both sides of the intensity histogram). Individual samples are processed on separate slides in single color mode (Cy5). The 75 percentile of intensity histogram is adjusted to 200 counts (a.u.) for normalization of the microarrays. The image analysis is configured in a way that allowed an automated assessment of the quality of individual fluorescence spots (criteria: local fluorescence background, spots symmetry, presence in salt image/Print QC). Only microarrays with >98% qualified spots are used for further analysis.
 
Submission date Apr 09, 2008
Last update date Apr 09, 2008
Contact name Wolfgang Ernst Gustav Budach
E-mail(s) [email protected]
Phone +41 61 6961391
Fax +41 61 6966212
Organization name Novartis Pharma AG
Department BMD/NV&D
Lab WKL-136.293
Street address Klybeckstrasse
City Basel
ZIP/Postal code 4002
Country Switzerland
 
Platform ID GPL6650
Series (1)
GSE11117 Molecular Classification and Prediction of Survival in Non-Small-Cell Lung Cancer

Data table header descriptions
ID_REF
VALUE Media Cybernetics ArrayPro Analyzer computed normalized net mean values

Data table
ID_REF VALUE
H200000001 0.00
H200000002 10.86
H200000005 16.72
H200000006 200.60
H200000007 4.96
H200000008 351.90
H200000010 18.76
H200000011 431.90
H200000012 0.45
H200000014 78.27
H200000016 247.80
H200000018 1318.00
H200000021 690.80
H200000022 34.06
H200000023 69.53
H200000024 56.74
H200000025 26.49
H200000029 125.30
H200000030 12.63
H200000034 1504.00

Total number of rows: 34592

Table truncated, full table size 577 Kbytes.




Supplementary file Size Download File type/resource
GSM280555.txt.gz 601.4 Kb (ftp)(http) TXT
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap